Amniotic Membrane and Mesenchymal Stem Cell Coalescence for Islet Transplantation in Experimental Diabetes in Rats

Documenti analoghi

• Chromatin Condensation Delays Senescence in Human Mesenchymal Stem Cells by Safeguarding Nuclear Damages during In Vitro Expansion
  di: Rohit Joshi, et al.
  Pubblicazione: (2024)
• Combination Therapy of Losartan and Fisetin Reduces Senescence and Enhances Osteogenesis in Human Bone Marrow–Derived Mesenchymal Stem Cells
  di: Haruki Nishimura, et al.
  Pubblicazione: (2025)
• Harnessing the Regenerative Potential of Fetal Mesenchymal Stem Cells and Endothelial Colony‐Forming Cells in the Biofabrication of Tissue‐Engineered Vascular Grafts (TEVGs)
  di: Angus Weekes, et al.
  Pubblicazione: (2024)
• Viewing Decellularized Amniotic Membrane Through the Lens of Coupled Scaffolding and Drug Delivery Systems in Regenerative Medicine
  di: Fatemeh Alibabaei-Omran, et al.
  Pubblicazione: (2025)
• Bilateral Crosslinking with Glutaraldehyde and 1-Ethyl-3-(3-Dimethylaminopropyl) Carbodiimide: An Optimization Strategy for the Application of Decellularized Human Amniotic Membrane in Tissue Engineering
  di: Fatemeh Alibabaei-Omran, et al.
  Pubblicazione: (2024)